Joao MD Siffert Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joao MD Siffert.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joao MD Siffert. Joao MD Siffert is Chief Executive Officer in ABEONA THERAPEUTICS INC. ($AKC) and SVP, R&D in AVANIR PHARMACEUTICALS, INC. ($AVNR) and Director in AveXis, Inc. ($AVXS).
Latest Insider Trading Transactions of Joao MD Siffert
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKC, AVNR, AVXS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 22 2020 | AKC | ABEONA THERAPEUTIC ... | Siffert Joao MD | Chief Executive Off ... | Option Exercise | A | 3.20 | 72,296 | 231,347 | 72,296 | |
May 22 2020 | AKC | ABEONA THERAPEUTIC ... | Siffert Joao MD | Chief Executive Off ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Mar 18 2020 | AKC | ABEONA THERAPEUTIC ... | Siffert Joao MD | Chief Executive Off ... | Option Exercise | A | 1.45 | 127,704 | 185,171 | 127,704 | |
Apr 18 2019 | AKC | ABEONA THERAPEUTIC ... | Siffert Joao MD | Chief Executive Off ... | Option Exercise | A | 6.70 | 110,000 | 737,000 | 110,000 | |
Apr 18 2019 | AKC | ABEONA THERAPEUTIC ... | Siffert Joao MD | Chief Executive Off ... | Option Exercise | A | 6.59 | 60,000 | 395,400 | 60,000 | |
Apr 11 2019 | AKC | ABEONA THERAPEUTIC ... | Siffert Joao MD | Chief Executive Off ... | Option Exercise | A | 7.24 | 100,000 | 724,000 | 100,000 | |
May 15 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | D | 69.25 | 7,755 | 537,034 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Sell | D | 0.00 | 1,106 | 0 | 0 | 1.1 K to 0 (-100.00 %) |
Mar 30 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
Mar 30 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
Jun 01 2017 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | A | 69.25 | 5,301 | 367,094 | 5,301 | |
Jun 01 2017 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
Feb 14 2014 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Grant | A | 0.00 | 43,000 | 0 | 233,980 | 191 K to 234 K (+22.52 %) |
Feb 14 2014 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Grant | A | 0.00 | 80,750 | 0 | 190,980 | 110.2 K to 191 K (+73.26 %) |
Dec 20 2013 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Sell | S | 2.63 | 5,970 | 15,713 | 110,230 | 116.2 K to 110.2 K (-5.14 %) |
Dec 17 2013 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Option Exercise | A | 2.84 | 47,500 | 134,900 | 47,500 | |
Sep 19 2013 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Option Exercise | M | 1.85 | 21,094 | 39,024 | 35,156 | |
Sep 19 2013 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Sell | S | 4.22 | 21,094 | 88,968 | 116,200 | 137.3 K to 116.2 K (-15.36 %) |
Sep 19 2013 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Buy | M | 1.85 | 21,094 | 39,024 | 137,294 | 116.2 K to 137.3 K (+18.15 %) |
Dec 19 2012 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Option Exercise | A | 2.59 | 75,000 | 194,250 | 75,000 | |
Dec 19 2012 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Grant | A | 0.00 | 34,875 | 0 | 116,200 | 81.3 K to 116.2 K (+42.88 %) |
Dec 19 2012 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Grant | A | 0.00 | 49,125 | 0 | 81,325 | 32.2 K to 81.3 K (+152.56 %) |
May 14 2012 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Buy | P | 2.96 | 2,700 | 7,992 | 32,200 | 29.5 K to 32.2 K (+9.15 %) |
Dec 16 2011 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Option Exercise | A | 1.85 | 56,250 | 104,063 | 56,250 | |
Dec 16 2011 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Grant | A | 0.00 | 21,375 | 0 | 29,500 | 8.1 K to 29.5 K (+263.08 %) |
Dec 16 2011 | AVNR | AVANIR PHARMACEUTI ... | Siffert Joao MD | SVP, R&D | Grant | A | 0.00 | 8,125 | 0 | 8,125 | 0 to 8.1 K |
Page: 1